Who owns the RENADYL trademark?

The RENADYL trademark is owned by Kibow Biotech LLC.

What class is the RENADYL trademark registered in?

The RENADYL trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for RENADYL?

The USPTO serial number for RENADYL is 98531377.

What is the registration number for RENADYL?

RENADYL is registered under USPTO registration number 7972325.

Sealvo

Home Search: RENADYLRENADYL #98531377

Back

Updated Sep 25, 2026·25 searches this week

View on USPTO TSDR Find similar marks

REN

USPTO Trademark Record

REGISTERED

RENADYL

SN 98531377·Reg 7972325·Filed May 02, 2024

Owner Kibow Biotech LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

RENADYL (Serial No. 98531377), Registration No. 7972325, is a registered US trademark filed on May 02, 2024 by Kibow Biotech LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: October 07, 2031

Conflict Analysis

Full conflict analysis for RENADYL (SN 98531377) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

RENADYL (Reg. #7972325) is a registered US trademark that has been protecting its owner, Kibow Biotech LLC, since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 4 opposition proceedings during prosecution.

FILED

May 02, 2024

SERIAL

98531377

REG#

7972325

REGISTERED

Oct 07, 2025

Filing Information

StatusREGISTERED

Filing DateMay 02, 2024

Serial Number98531377

Registration No.7972325

Registration DateOct 07, 2025

Status DateOct 07, 2025

Published for OppositionDec 10, 2024

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Nov 30, 2011

First use in commerce: Nov 30, 2011

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

20 events

REGISTERED-PRINCIPAL REGISTER

Oct 07, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 07, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 03, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

OPPOSITION DISMISSED NO. 999999

Sep 16, 2025

OPPOSITION DISMISSED NO. 999999

OPPOSITION TERMINATED NO. 999999

Sep 16, 2025

OPPOSITION TERMINATED NO. 999999

TTAB RELEASE CASE TO TRADEMARKS

Sep 16, 2025

TTAB RELEASE CASE TO TRADEMARKS

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

Jun 08, 2025

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

OPPOSITION INSTITUTED NO. 999999

Jun 07, 2025

OPPOSITION INSTITUTED NO. 999999

EXTENSION OF TIME TO OPPOSE RECEIVED

Dec 23, 2024

EXTENSION OF TIME TO OPPOSE RECEIVED

PUBLISHED FOR OPPOSITION

Dec 10, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 10, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 04, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO EXAMINER

Nov 18, 2024

ASSIGNED TO EXAMINER

EXAMINERS AMENDMENT -WRITTEN

Nov 18, 2024

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Nov 18, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 18, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Nov 18, 2024

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 18, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

NEW APPLICATION ENTERED

May 02, 2024

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 02, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by Kibow Biotech LLC

Additional USPTO filings from the same owner.

KIB

KIBOW FORTIS

86404842

KIBOW BIOTECH LLC

REGISTERED

KIB

KIBOW

76471480

KIBOW BIOTECH LLC

REGISTERED

ENT

ENTERIC DIALYSIS

76610241

KIBOW BIOTECH LLC

REGISTERED

INT

INTESTINAL DIALYSIS

97148493

KIBOW BIOTECH LLC

REGISTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

REN

RENADYL

85294905

Kibow Biotech, Inc.

ABANDONED

Other Marks by LUNA M. SAMMAN

Additional USPTO filings handled by the same attorney of record.

STI

STIFEL DONOR-ADVISED FUNDS

88715003

REGISTERED

CIS

CISPRO

78500083

REGISTERED

STI

STIFEL CHARITABLE

88553993

REGISTERED

LOG

LogoMark

88737684

REGISTERED

RENADYL

Run a conflict check

Other Marks by Kibow Biotech LLC

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by LUNA M. SAMMAN

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company